Trump Signs Executive Order Creating Women's Health Task Force and NIH Division President Donald Trump signed an executive order creating a White House women's health task force and a new NIH Women's Health Division. First lady Melania Trump is expected to highlight artificial intelligence and care access at the signing. WASHINGTON - U.S. President Donald Trump signed an executive order alongside first lady Melania Trump on Monday creating a task force and a National Institutes of Health division focused on women's health, the White House said. Wiles And Kennedy Lead Health EffortThe signing was announced in a post on X. The post said the order aims to close research gaps and modernize care for women. The task force will be led by Trump's White House chief of staff Susie Wiles, who recently announced that she is cancer-free. U.S. Health Secretary Robert F. Kennedy Jr. will co-lead the effort. The new Women's Health Division at the National Institutes of Health will not replace the agency's Office of Research on Women's Health.It will have a broader mandate beyond research. In planned remarks at the event, Melania Trump is expected to address the need for using artificial intelligence to speed women's health discoveries. She is also expected to discuss access and affordability of care. Representatives for the Department of Health and Human Services, which oversees the NIH, could not be immediately reached for comment.The order was first reported by USA Today. Trump and his administration have pushed for healthcare cuts, including at NIH. Last year, the administration moved to downsize the federal healthcare workforce. During Trump's second term, his administration sought to cut NIH grants for research on diversity-related topics.Cuts And Reviews Draw CriticismIt reportedly is moving to allow political appointees to control health-research funding. The administration also launched a controversial safety review of the abortion pill, mifepristone, that could pave the way for restrictions. Major medical groups have criticized the move as politically motivated. Anti-abortion groups argue the review is moving too slowly.Earlier this month, U.S. officials told a court the review would be completed by March. U.S. health officials also removed a longstanding safety warning from many hormone replacement therapy products. The change tightened supplies and led to shortages. Officials have urged more manufacturers to study testosterone therapies for women.That research could support future approvals of female-specific products. HHS has also targeted family planning funds. Earlier this year, the department announced it would require applicants for Title X funding to align their programs with Trump's political priorities. The requirement prompted legal action.Task Force Aims To Close GapsThe signing event took place in Washington, where Trump and Melania Trump appeared together. The newly announced task force and NIH division are intended to address women's health research and care. The White House said the effort will focus on closing gaps and modernizing treatment. The order combines a White House policy task force with a division inside the nation's top medical research agency.Wiles and Kennedy will lead the task force, according to a White House official. Melania Trump's expected remarks will center on technology and patient costs. The official said artificial intelligence could help speed discoveries in women's health. The broader policy record includes cuts and reviews that have drawn criticism from medical groups.The administration has defended its health agenda while facing legal and political pushback. The mifepristone review remains pending, with officials telling a court it would be finished by March. The hormone therapy warning change and Title X funding requirements are also part of the administration's recent health actions.